Merlin (MRLN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
22 May, 2026Executive summary
Incorporated on June 24, 2024, as a blank check company to pursue a business combination, with no operations or revenues to date and a focus on the TMT sector and technology-driven industries.
Completed IPO on November 4, 2024, raising $250 million from 25,000,000 units at $10.00 per unit, with an additional $4.25 million from a private placement.
All IPO proceeds placed in a trust account, to be used for a future business combination; no target identified as of the report date.
Financial highlights
Net loss of $47,447 for the three months ended September 30, 2024, and $77,427 for the period from inception through September 30, 2024, driven by formation and operating costs.
Total assets of $295,206 as of September 30, 2024, primarily deferred offering costs; working capital deficit of $346,463.
No revenues generated; all activity related to formation and IPO preparation.
Outlook and guidance
Management expects no operating revenues until a business combination is completed.
Sufficient funds are available for at least one year from the issuance date; additional financing may be needed if costs exceed estimates or for a business combination.
Latest events from Merlin
- SPAC raising $250M to target tech sectors, offering redemption rights but with dilution risks.MRLN
Registration filing22 May 2026 - $250M SPAC IPO targets tech-driven sectors, offering redemption rights but with dilution risks.MRLN
Registration filing22 May 2026 - SPAC targets TMT sectors with $250M IPO, but public shareholders face dilution and execution risks.MRLN
Registration filing22 May 2026 - $250M IPO targets tech-driven sectors, with sponsor/insider control and potential dilution for public shareholders.MRLN
Registration filing22 May 2026 - Autonomous flight tech firm with strong government ties, high losses, and major resale share overhang.MRLN
Registration filing22 May 2026 - Secondary sale of 13.3M shares by a major investor; no IPO proceeds to company; high growth, high risk.MRLN
Registration filing22 May 2026 - $250M raised, $1.52M net income, no target yet; must complete a deal by Nov 2026.MRLN
Q4 202422 May 2026 - 2025 net income reached $6.0M; business combination with Merlin Labs set for March 2026.MRLN
Q4 202522 May 2026 - Revenue up 15.4% year-over-year, net loss widened, and liquidity rose to $183M post-financing.MRLN
Q1 202622 May 2026